Literature DB >> 14748762

Undocumented drug utilization and drug waste increase costs of pediatric anesthesia care.

Alejandro A Nava-Ocampo1, Juan M Alarcón-Almanza, Diana Moyao-García, Juan Carlos Ramírez-Mora, Jorge Salmerón.   

Abstract

The present study was performed in order to identify the cost of drugs used without documenting them in the patients' file and the wastage of drugs in a pediatric anesthesiology ward. In a prospective, blinded, observational design, drug utilization of 610 consecutive patients, undergoing an elective or emergency surgical procedure was evaluated. The number of undocumented drugs per 100 requested units and the number of wasted drugs per 100 requested units were computed and multiplied by its corresponding unitary cost. The median undocumented cost was 92.4 US dollars (95% CI 17.2-216.6 dollars) per 100 requested units. Succinylcholine (40 mg/2 mL) was the main undocumented drug; its use was not documented in approximately 50% cases in which this neuromuscular blocking agent was requested. However, rocuronium and nalbuphine had the highest unjustified cost, 770.6 dollars and 847.0 dollars per 100 requested units, respectively. Ketorolac, diclofenac, metamizol, furosemide, methylprednisolone, sodium bicarbonate, and cisatracurium were requested and documented. The median cost of wasted drug was 141.8 dollars (95% CI 55.8-448.2 dollars) per 100 requested drugs. More than 80% of adrenaline, naloxone, flunitrazepam, ephedrine, and cisatracurium were wasted. However, the highest cost of wasted drugs was for ondansetron, cisatracurium, methylprednisolone, and rocuronium. The uncontrolled availability and use of drugs may represent an important amount of resources wasted without any awareness of the staff in a department of pediatric anesthesia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14748762     DOI: 10.1046/j.0767-3981.2003.00214.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  8 in total

1.  Computer-assisted management of unconsumed drugs as a cost-containment strategy in oncology.

Authors:  Renaud Respaud; Jean-François Tournamille; Gael Saintenoy; Claude Linassier; Claire Elfakir; Marie-Claude Viaud-Massuard; Daniel Antier
Journal:  Int J Clin Pharm       Date:  2014-07-13

2.  An Anticancer Drug Unit for the whole provincial oncologic network of Piacenza: improving safety and savings.

Authors:  Patrizia Mordenti; Stefano Vecchia; Enrico Damonti; Alessandra Riva; Monica Muroni; Maria Rosa Cordani; Gabriele Cremona; Luigi Cavanna
Journal:  Med Oncol       Date:  2015-01-09       Impact factor: 3.064

3.  Drug Audit of Intravenous Anaesthetic Agents in Tertiary Care Hospital.

Authors:  Sonali Ramakant More; Sangeeta Sanjay Dabhade; Balasaheb Baburao Ghongane
Journal:  J Clin Diagn Res       Date:  2015-11-01

4.  Drug waste minimization as an effective strategy of cost-containment in oncology.

Authors:  Gianpiero Fasola; Giuseppe Aprile; Luisa Marini; Alessandro Follador; Mauro Mansutti; Manuela Miscoria
Journal:  BMC Health Serv Res       Date:  2014-02-07       Impact factor: 2.655

5.  Financial Implications of Intravenous Anesthetic Drug Wastage in Operation Room.

Authors:  Suvarna Kaniyil; A Krishnadas; Arun Kumar Parathody; K T Ramadas
Journal:  Anesth Essays Res       Date:  2017 Apr-Jun

6.  Cost drain of anesthesia emergency drugs in a quaternary care hospital.

Authors:  Amer Majeed; Attyia Firdous; Hesham AlBabtain; Tahir Iqbal
Journal:  Saudi J Anaesth       Date:  2019 Jul-Sep

7.  Drug waste minimisation and cost-containment in Medical Oncology: two-year results of a feasibility study.

Authors:  Gianpiero Fasola; Marianna Aita; Luisa Marini; Alessandro Follador; Marina Tosolini; Laura Mattioni; Mauro Mansutti; Andrea Piga; Silvio Brusaferro; Giuseppe Aprile
Journal:  BMC Health Serv Res       Date:  2008-04-01       Impact factor: 2.655

8.  The status of drug wastage in the pediatric emergency department of a tertiary hospital.

Authors:  Ibrahim Hakan Bucak; Habip Almis; Cagla Nur Dogan; Mehmet Turgut
Journal:  Avicenna J Med       Date:  2020-01-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.